Kovack Advisors, Inc. - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Kovack Advisors, Inc. ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$123,060
+7.6%
42,000
+5.0%
0.02%
+13.3%
Q2 2023$114,400
+5.8%
40,000
+14.3%
0.02%0.0%
Q1 2023$108,150
+105.0%
35,000
+40.0%
0.02%
+87.5%
Q4 2022$52,750
-76.2%
25,000
-20.6%
0.01%
-65.2%
Q1 2022$222,00031,5000.02%
Other shareholders
HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,177,0004.71%
Endowment Wealth Management, Inc. 96,618$682,0000.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 36,171$255,0000.24%
Prescott General Partners LLC 625,100$4,413,0000.20%
CenterBook Partners LP 45,752$323,0000.12%
Gladstone Institutional Advisory LLC 144,867$1,0230.07%
Exos Asset Management LLC 18,609$131,0000.06%
Sciencast Management LP 26,300$182,0000.04%
Y-Intercept (Hong Kong) Ltd 17,125$121,0000.03%
Kovack Advisors, Inc. 31,500$222,0000.02%
View complete list of HUMACYTE INC shareholders